azacitidine has been researched along with Acute Febrile Neutrophilic Dermatosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, R; Wang, J; Wu, DY; Yan, XJ; Zhang, R | 1 |
| Bairwa, S; Patra, S; Thirunavukkarasu, B; Waghmare, P | 1 |
| Berry, WA; Kelly, R | 1 |
| Bhari, N; Dev, T; Dudani, P | 1 |
| Ito, S; Kudo, D; Kuroda, A; Shimizu, M; Shinagawa, A; Suyama, T | 1 |
| Caccetta, T; Harvey, N; Kumarasinghe, SP; Tiwari, SM | 1 |
| Billings, S; Englehaupt, R; Hasrouni, E; Kalaycio, M; Liu, Y; Rogers, HJ; Saunthararajah, Y; Sekeres, MA; Tabarroki, A; Tiu, RV; Visconte, V | 1 |
| Ishii, S; Itoh, T; Katayama, Y; Kawano, H; Kawano, Y; Minagawa, K; Sada, A; Suzuki, T; Ueno, D; Wakahashi, K; Yamasaki, T; Yokozaki, H | 1 |
| Cavazzini, F; Cibien, F; Cuneo, A; Daghia, G; Gafà, R; Leo, G; Lista, E; Martinelli, S; Rigolin, GM; Sofritti, O | 1 |
| Lin, CH; Lin, TY; Yeh, SP | 1 |
| Bouffioux, B; Courtin, C; Janssens, P; Ngendahayo, P; Saint-Remy, A; Voogeleer, MN | 1 |
| Abramowtiz, M; Alencar, C; Braunshweig, I; Jacobson, M; Parekh, S; Silverman, L; Verma, A | 1 |
| Halasz, C; Patel, V; Ruskin, A; Tintle, S | 1 |
| Aw, D; Goh, BC; Hsieh, WS; Lee, SC; Pang, A; Tan, KB | 1 |
| Craig, M; Cumpston, A; Trickett, HB | 1 |
2 review(s) available for azacitidine and Acute Febrile Neutrophilic Dermatosis
| Article | Year |
|---|---|
Response of autoimmune and inflammatory disorders in myelodysplastic syndromes to 5-azacytidine: report of two cases and literature review.
Topics: Aged; Azacitidine; Humans; Male; Myelodysplastic Syndromes; Sweet Syndrome | 2021 |
Myelodysplastic syndrome with neutrophilic dermatosis successfully treated with azacitidine.
Topics: Aged; Azacitidine; Humans; Male; Myelodysplastic Syndromes; Sweet Syndrome; Treatment Outcome | 2017 |
13 other study(ies) available for azacitidine and Acute Febrile Neutrophilic Dermatosis
| Article | Year |
|---|---|
Azacytidine-induced Sweet's syndrome.
Topics: Azacitidine; Diagnosis, Differential; Humans; Sweet Syndrome | 2022 |
A case of polycyclic Sweet's syndrome arising from azacitidine injection sites in myelodysplasia.
Topics: Aged; Azacitidine; Humans; Male; Myelodysplastic Syndromes; Sweet Syndrome | 2020 |
Azacytidine induced localized Sweets syndrome in Myelodysplastic syndrome.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Humans; Myelodysplastic Syndromes; Sweet Syndrome | 2021 |
Azacitidine-induced Sweet syndrome: Two unusual clinical presentations.
Topics: Abdominal Wall; Antimetabolites, Antineoplastic; Azacitidine; Biopsy, Needle; Female; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Risk Assessment; Sampling Studies; Severity of Illness Index; Sweet Syndrome; Treatment Outcome | 2018 |
Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet syndrome that was refractory to 5-azacitidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Male; Middle Aged; Primary Myelofibrosis; Risk Factors; Sweet Syndrome; Treatment Outcome | 2014 |
Recurrence of abdominal large-vessel vasculitis and development of severe Sweet syndrome after a single cycle of 5-azacytidine in a patient with myelodysplastic syndrome.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Fatal Outcome; Humans; Male; Myelodysplastic Syndromes; Sweet Syndrome; Vasculitis | 2014 |
Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome.
Topics: Aged; Azacitidine; Biopsy; Bone Marrow; Humans; Male; Myelodysplastic Syndromes; Skin; Sweet Syndrome; Treatment Outcome | 2014 |
Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome.
Topics: Azacitidine; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Sweet Syndrome; Treatment Outcome | 2015 |
[Vesiculobullous Sweet's syndrome].
Topics: Abdomen; Aged; Anemia, Aplastic; Antimetabolites, Antineoplastic; Azacitidine; Fatal Outcome; Humans; Immunocompromised Host; Injections, Subcutaneous; Male; Shock, Septic; Sweet Syndrome | 2017 |
Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Decitabine; Diagnosis, Differential; Fatal Outcome; Female; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Sweet Syndrome; Treatment Outcome | 2009 |
Azacitidine: a new medication associated with Sweet syndrome.
Topics: Aged; Azacitidine; Drug Eruptions; Enzyme Inhibitors; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Myelodysplastic Syndromes; Recurrence; Sweet Syndrome | 2011 |
A case of Sweet's syndrome due to 5-Azacytidine and vorinostat in a patient with NK/T cell lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Female; Humans; Hydroxamic Acids; Lymphoma, Extranodal NK-T-Cell; Sweet Syndrome; Vorinostat | 2012 |
Azacitidine-associated Sweet's syndrome.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Azacitidine; Biopsy; Drug Eruptions; Humans; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Skin; Sweet Syndrome | 2012 |